View More Recent Stories

Jun 14, 2024 07:01AM Kymera Therapeutics (KYMR) Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
View More Recent Stories